ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Impact of Retroactive Application of Updated Surveillance Guidelines on Endoscopy Center Capacity at a Large VA Health Care System.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In 2020, the US Multi-Society Task Force (USMSTF) on Colorectal Cancer revised its recommended interval for surveillance of 1 to 2 subcentimeter tubular adenomas from 5 to 10 years to 7 to 10 years. This study assessed the impact of retroactively applying these guidelines on endoscopy center capacity. Methods: Colonoscopy reports were reviewed for patients with an upcoming colonoscopy reminder at the Veterans Affairs Pittsburgh Healthcare System (VAPHS). Patients with incomplete records, high-risk indications, or inadequate bowel preparation were excluded. Previous surveillance recommendations were compared with the 2020 USMSTF guideline to determine whether colonoscopy intervals could be extended. Results: Of 583 patients, 331 (56.7%) had adequate data to determine extendibility. Using the 2020 USMSTF guidelines, colonoscopy interval could be extended by ≥ 1 year for 64 patients (11%) for a total of 153 years extended. For 36 patients, the ability to extend the colonoscopy interval was directly attributable to the updated 2020 USMSTF guideline. Conclusions: Retroactive application of USMSTF surveillance guidelines could modestly increase endoscopic capacity, but overall impact may be limited by fragmentation of care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.